GlenRock Israel
About Us Investments Added Value Services Management Venture Partners Community Responsibility Contact Us
Venture Partners
Rhodium

Rhodium is a private investing firm, focusing on high growth cutting-edge opportunities in the fields of Internet, New-media, Mobile and new technologies in general.
Our mission is to identify the most promising entrepreneurs and help them to build thriving companies.
Our focus on diverse innovative technology start-up ventures stems from our passion and experience in the field, which enable us to bring substantial and sustainable value and commitment to entrepreneurs.
Our commitment is to support entrepreneurs and strengthen their ventures with our resources: funding, broad management expertise and an extensive valuable network of business contacts around the globe.
We stand to take an active role in most of our portfolio companies. We strategically invest in a handful of promising companies each year to allow us to be actively involved in creating the optimum environment for them to successfully transform into world class business ventures.
We are dedicated to value creation through each phase of the firmís life-cycle, from early-stage to market leadership.
Regardless of the size of our initial investment, we like to continue to support our portfolio companies throughout their financing lifecycles.
Our passion is partnering with talented entrepreneurs to turn their ideas into industry-leading companies that will make a difference in our world.
http://www.rhodium.co.il/


NGN Capital

Leon Recanati a Venture Partner in NGN BioMed II, works with NGN Capital on fund raising from Israeli institutional and private investors, and thereafter in identifying and investing in mid/late stage Israeli based healthcare companies.
NGN II, with $180M, has flexibility to invest in a broad cross section of Healthcare and Biotechnology segments and intends on committing 10% of the fund to investments in Israeli healthcare companies.
Asaf Iram will manage the joint operation with NGN on behalf of GlenRock Israel.
NGN II is a Venture Capital fund dedicated to Healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The fund is diversified by stage, from later stage to selected early stage opportunities.
Read more about NGN Capital..